R-026

瑞芬太尼标准液 溶液

100 μg/mL in acetonitrile, certified reference material, Cerilliant^®

• 經驗公式（希爾表示法）: C₁₉H₂₆N₂O₅
• CAS號碼: 132875-68-4
• 分子量：: 362.42
• 分類程式碼代碼: 41116107
• NACRES: NA.24

屬性

• 等級: certified reference material
• 品質等級: 300
• 形狀: liquid
• 特點: Snap-N-Spike^®/Snap-N-Shoot^®
• 包裝: ampule of 1 mL
• 製造商／商標名: Cerilliant^®
• 濃度: 100 μg/mL in acetonitrile
• 技術: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• 應用: forensics and toxicology
• 格式: single component solution
• 儲存溫度: −20°C
• InChI: 1S/C19H26N2O5/c1-3-16(22)21(15-7-5-4-6-8-15)19(18(25)26-2)10-13-20(14-11-19)12-9-17(23)24/h4-8H,3,9-14H2,1-2H3,(H,23,24)
• InChI 密鑰: GFJKFSFFMHOISI-UHFFFAOYSA-N

描述

一般說明

瑞芬太尼酸是瑞芬太尼的主要尿代谢产物，瑞芬太尼是一种用于诱导或补充全身麻醉的合成阿片类药物。这种新的认证参比溶液适用于包括临床毒理学、法医分析、工作场所药物测试和药学研究在内的多种基于质谱的测试应用。

應用

• Glycogen synthase kinase-3 beta inhibition prevents remifentanil-induced postoperative hyperalgesia via regulating the expression and function of AMPA receptors: This study investigates the mechanisms behind remifentanil-induced hyperalgesia, using remifentanil acid as a key component to understand pain modulation post-surgery. The findings are essential for developing targeted pain management therapies in postoperative care, making it a crucial study for researchers in pharmaceutical and analgesic drug development (Li et al., 2014).


• Quantitative measurement of blood remifentanil concentration: development of a new method and clinical application: This research develops a new methodology for quantifying blood levels of remifentanil, providing insights into its pharmacokinetics and pharmacodynamics. This method is significant for clinical settings where precise dosing and monitoring are crucial, offering valuable data for pharmacological research and safe anesthetic practices (Kudo et al., 2013).


• Erasure of a spinal memory trace of pain by a brief, high-dose opioid administration: This groundbreaking study explores the potential for high-dose opioids like remifentanil to erase painful memories at the spinal level, potentially revolutionizing approaches to chronic pain management. This research is of paramount importance to neuroscientists and clinical researchers focusing on new therapeutic strategies for pain relief (Drdla-Schutting et al., 2012).


• Distinct mechanisms underlying pronociceptive effects of opioids: This study further elucidates the complex mechanisms by which opioids like remifentanil may exacerbate pain under certain conditions. By exploring the molecular interactions involved, this research contributes to a deeper understanding of opioid pharmacology and aids in the development of better analgesic agents with fewer side effects (Heinl et al., 2011).


• Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [(18)F]fallypride positron emission tomography study: This innovative study uses remifentanil to examine how opioid administration affects dopamine release in subjects with varying levels of alcohol dependence. The results are critical for understanding addiction and developing personalized treatment strategies that consider underlying co-dependencies (Spreckelmeyer et al., 2011).

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

安全資訊

• 象形圖: GHS02,GHS07
• 訊號詞: Danger
• 危險聲明: H225,H302 + H312 + H332,H319
• 防範說明: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P305 + P351 + P338
• 危險分類: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2
• 儲存類別代碼: 3 - Flammable liquids
• 水污染物質分類（WGK）: WGK 2
• 閃點（°F）: 35.6 °F - closed cup
• 閃點（°C）: 2.0 °C - closed cup